Congress trades and big insider sales, sent the day they're filed. Free.
Open in Telegram
Director · ImmunityBio, Inc. · Common Stock
Open-market sale
$188K reported value · 100.0% of prior position
Disclosed 1 business day after execution (deadline: 2)
1 prior trade recorded in this security
No clustered activity in the dataset
No material company filing within 60 days after the trade
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 20 | Lisa C. McClainRSpouse | Purchase | BUY | $1,001 – $15K | Oct 12, 2026 traded Sep 30, 2026 | |
| 24 | Lisa C. McClainRSpouse | Purchase | BUY | $1,001 – $15K | Oct 12, 2026 traded Sep 28, 2026 | |
| 8 | Simon Barry J.Director | Open-market sale · 10b5-1 plan | SELL | $197K 25.0K sh | Jun 26, 2026 traded Jun 24, 2026 | |
| 5 | Selecky ChristobelDirector | Grant or award | A | — 65.6K sh | Jun 10, 2026 traded Jun 9, 2026 | |
| 9 | Maxwell LindaDirector | Grant or award | A | — 65.6K sh | Jun 10, 2026 traded Jun 9, 2026 | |
| 19 | Sachs David C.Chief Financial Officer | Tax withholding | F | $296K 42.6K sh | Feb 12, 2026 traded Feb 10, 2026 | |
| 17 | Sachs David C.Chief Financial Officer | Option exercise | M | — 82.2K sh | Feb 12, 2026 traded Feb 10, 2026 | |
| 21 | Sachs David C.Chief Financial Officer | Option exercise | M | — 82.2K sh | Feb 12, 2026 traded Feb 10, 2026 | |
| 3 | Selecky ChristobelDirector | Option exercise · 10b5-1 plan | M | — 25.0K sh | Jan 21, 2026 traded Jan 20, 2026 | |
| 29 | Selecky ChristobelDirector | Open-market sale · 10b5-1 plan | SELL | $250K 50.0K sh | Jan 21, 2026 traded Jan 16, 2026 | |
| 0 | Selecky ChristobelDirector | Option exercise · 10b5-1 plan | M | $75K 25.0K sh | Jan 21, 2026 traded Jan 20, 2026 | |
| 8 | Selecky ChristobelDirector | Option exercise · 10b5-1 plan | M | $149K 50.0K sh | Jan 21, 2026 traded Jan 16, 2026 | |
| 17 | Selecky ChristobelDirector | Option exercise · 10b5-1 plan | M | — 50.0K sh | Jan 21, 2026 traded Jan 16, 2026 |
Read directly from the primary public document; every field below is as reported by the filer.
Value = shares × reported price per share
= $187,650
Selecky Christobel filed this Form 4 reporting a open-market sale of IBRX on Jan 20, 2026. It became public on Jan 21, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
No field has changed since this record was first ingested.
No material filings recorded for this issuer.